Clinical Trial Results:
            A multi-center, open label Phase II trial of TKI258 in FGFR1 amplified and non-amplified metastatic HER2 negative breast cancer.
    
|     Summary | |
|     EudraCT number | 2008-006430-10 | 
|     Trial protocol | FI ES FR GB IT | 
|     Global completion date | 
                                    02 Mar 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    16 Sep 2016
                             | 
|     First version publication date | 
                                    16 Sep 2016
                             | 
|     Other versions | |
|     Summary report(s) | CTKI258A2202.CTR.23Aug2016 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
